Category: Rumors

Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms

Evolent Health Inc (NYSE:EVH) is reportedly up for sale. What Happened: The Arlington, Virginia-based software provide initiated an auction process after receiving takeover inquiries from private equity firms and healthcare providers. Among the potential suitors are private equity giants TPG Inc (NASDAQ:TPG), Clayton, Dubilier & Rice (CD&R), and KKR & Co. Inc. (NYSE:KKR). Notably, TPG […]

Investors Heavily Search Pure Storage, Inc.: Here is What You Need to Know

Pure Storage (NYSE: PSTG) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month, shares of this data storage company have returned +0.5%, compared to the Zacks S&P […]

Consol Energy And Arch Resources To Merge In $5B Domestic Coal Entity

Arch Resources (NYSE:ARCH) and Consol Energy (NYSE:CEIX), two of the largest coal miners in the United States, are entering a merger that will create a $5.2 billion coal mining company. “This merger will join two proven leadership teams and best-in-sector operating platforms to establish a premier North American coal producer with worldwide reach and world-class […]

Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions

Roche Holding AG (OTC:RHHBY) is reportedly contemplating the divestiture of Flatiron Health, a cancer data specialist Roche acquired in 2018 for $1.9 billion. The move underscores the complexities and potential pitfalls that large pharmaceutical companies encounter when investing in early-stage health technology firms. Also Read: Roche’s New Immunotherapy Fails To Show Benefit Over Merck’s Blockbuster […]

Is Trending Stock Navios Maritime Partners LP a Buy Now?

Navios Maritime Partners LP (NYSE: NMM) has recently been on Zacks.com’s list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock’s performance in the near future. Shares of this company have returned -6.8% over the past month versus the Zacks S&P 500 composite’s […]

Carlyle Eyes $4B Acquisition Of Baxter’s Kidney-Care Unit Vantive: Report

Carlyle Group (NYSE:CG) is reportedly in exclusive talks to acquire Baxter International Inc.’s (NYSE:BAX) kidney-care spinoff, Vantive, in a deal valued at over $4 billion, including debt. The companies began exclusive negotiations in late June, the Wall Street Journal reported, citing sources familiar with the matter. An agreement could be announced in the coming weeks, […]

German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount

German drug developer Evotec SE (NASDAQ:EVO) is reportedly consulting defense advisers following a significant drop in share price, raising concerns about the company’s vulnerability to a takeover. Multiple buyout firms are reportedly evaluating Hamburg-based Evotec as a potential acquisition target, initiating early discussions with advisers to assess the company’s drug pipeline and strategic value. Evotec’s […]